Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aker BioMarine ASAFRA:1PG +6.12%63 PS Ratio is 4.25 as of Aug. 04, 2026, which is 84% above its 10-year median of 2.31. GuruFocus rates FRA:1PG with a GF Score™ of 63/100 and a GF Value™ of €6.45 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 1,940 Consumer Packaged Goods companies, Aker BioMarine ASA ranks worse than 89.23% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Aker BioMarine ASA's share price is €9.89.
Aker BioMarine ASA's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was €2.33. Hence, Aker BioMarine ASA's PS Ratio for today is 4.25.
Warning Sign:
Aker BioMarine ASA stock PS Ratio (=4.14) is close to 10-year high of 4.44.
The historical rank and industry rank for Aker BioMarine ASA's PS Ratio or its related term are showing as below:
FRA:1PG'
s PS Ratio Range Over the Past 10 Years
Min: 1.01 Med: 2.31 Max: 4.44
Current: 3.9
During the past 13 years, Aker BioMarine ASA's highest PS Ratio was 4.44. The lowest was 1.01. And the median was 2.31.
FRA:1PG's PS Ratio is ranked worse than 89.23% of 1940
companies
in the Consumer Packaged Goods industry
Industry Median: 0.85
vs FRA:1PG: 3.90
Aker BioMarine ASA revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue per Share Growth Rate of Aker BioMarine ASA was 5.80% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -7.00% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -4.70% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 31.90% per year.
During the past 13 years, Aker BioMarine ASA's highest 3-Year average Revenue per Share Growth Rate was 398.60% per year. The lowest was -45.00% per year. And the median was -1.80% per year.
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Aker BioMarine ASA PS Ratio Related Terms
Aker BioMarine ASA PS Ratio Historical Data
* Premium members only.
The historical data trend for Aker BioMarine ASA's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Aker BioMarine ASA's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aker BioMarine ASA PS Ratio vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Aker BioMarine ASA's PS Ratio distribution charts can be found below:
* The bar in red indicates where Aker BioMarine ASA's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Aker BioMarine ASA's Share Price of today is €9.89.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Aker BioMarine ASA's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was €2.33.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Aker BioMarine ASA (FRA:1PG) has a PS Ratio of 4.25 as of Aug. 04, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Aker BioMarine ASA and its competitors. This is 84% above median its historical median of 2.31. Over the past decade, Aker BioMarine ASA's PS Ratio has ranged from 1.01 to 4.44. According to the industry distribution chart, Aker BioMarine ASA ranks #1731 out of 1940 companies in the Consumer Packaged Goods industry, placing it in the top 89.2%.
Is Aker BioMarine ASA's PS Ratio too high?
Aker BioMarine ASA's current PS Ratio of 4.25 is 84% above median its 10-year median of 2.31. Over the past 10 years, this metric has ranged from a low of 1.01 to a high of 4.44. The Consumer Packaged Goods industry median PS Ratio is 0.85. Aker BioMarine ASA's value of 4.25 is 400% above this industry median. Based on the distribution chart, Aker BioMarine ASA ranks #1731 out of 1940 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Aker BioMarine ASA has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aker BioMarine ASA's PS Ratio compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Aker BioMarine ASA ranks #1731 out of 1940 companies for PS Ratio. This places Aker BioMarine ASA in the lower half of its industry. The industry median PS Ratio is 0.85. Aker BioMarine ASA's value of 4.25 is 400% above this benchmark. Historically, Aker BioMarine ASA's own PS Ratio has ranged from 1.01 to 4.44 over the past decade. While the company's 10-year median is 2.31 vs. the industry median of 0.85, Aker BioMarine ASA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Consumer Packaged Goods company?
The median PS Ratio among Consumer Packaged Goods companies is 0.85, based on 1,940 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aker BioMarine ASA's current PS Ratio of 4.25 is 400% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Aker BioMarine ASA and its competitors. For the Consumer Packaged Goods industry, the median PS Ratio is 0.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aker BioMarine ASA's current PS Ratio is 4.25, which is 84% above median its own 10-year median of 2.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aker BioMarine ASA stock overvalued right now?
Based on GuruFocus' analysis, Aker BioMarine ASA (FRA:1PG) is currently considered Significantly Overvalued. The stock's GF Value™ is €6.45, compared to a current price of €9.89 — trading 53.3% above its estimated fair value. The current PS Ratio is 4.25, which is 84% above median its 10-year median of 2.31 and 400% above the Consumer Packaged Goods industry median of 0.85. Aker BioMarine ASA's overall GF Score™ is 63/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Aker BioMarine ASA (FRA:1PG), the current PS Ratio is 4.25 as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aker BioMarine ASA (FRA:1PG) Overvalued in 2026?
Based on GuruFocus' analysis, Aker BioMarine ASA stock appears to be overvalued.
The current stock price of €9.89 is trading 53.3% above its estimated GF Value™ of €6.45.
GuruFocus considers Aker BioMarine ASA to be Significantly Overvalued.
Key valuation signals for FRA:1PG:
PS Ratio: 4.25 (84% above median its 10-year median of 2.31)
GF Value™: €6.45 vs. price of €9.89 (53.3% above fair value)
Industry Position: 400% above the Consumer Packaged Goods median (#1731 of 1940)
No single metric tells the full story. See the FRA:1PG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aker BioMarine ASA is a supplier of krill-derived products, with a fully owned supply chain. The operations of the company span from harvesting krill in Antarctica with vessels owned by the company including distribution from Uruguay, and further processing of the krill into oil products in the United States. The segments of the company include Human Health Ingredients, Consumer Health Products, and Emerging Businesses. The company generates the majority of its revenue from the Human Health Ingredients segment, which includes Superba, Lysoveta, PL+ Algae, and the company's Houston manufacturing plant. The segment sells B2B krill oil supplements to nutritional brands for humans around the world.
63GF Score
Get the complete analysis for FRA:1PG
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:1PG has been successfully added to your 
